Viemed Healthcare US (VMD) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Viemed Healthcare has reported a strong start to 2024 with first-quarter revenues up 28% to $50.6 million and a 21% increase in Adjusted EBITDA, reflecting the company’s successful operational enhancements and strategic growth efforts. With a robust cash balance and no net debt, the company is well-positioned for future expansion, including a new joint venture that underscores its role as a leader in home healthcare innovations. Looking forward, Viemed anticipates continued revenue growth in the second quarter of 2024.
For further insights into VMD stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue